ASTONEA LABS LIMITED Share Price

ASTONEA LABS LIMITED Share Price

BSE: 544409
|
Pharmaceuticals
|
S Cap
₹ 332.00
-₹12.50 (-3.63%)
1D
Last updated 22 Sep, 2026, 15:27 IST

ASTONEA LABS LIMITED Share Price Today

As of 23 Sep 2026, ASTONEA LABS LIMITED share price is ₹332.00. The stock opened at ₹319.95, compared to its previous close of ₹344.50. During today's trading session, ASTONEA LABS LIMITED share price moved in the range of ₹319.95 to ₹332.10, with an average price of ₹326.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹118.00 and a high of ₹369.00.

₹319.95
3.63% down today
₹332.10
1D LOW
1D HIGH

ASTONEA LABS LIMITED Returns Calculator

Circuit
L
H
₹298.85
₹365.25
52-week
L
H
₹118.00
₹369.00

About ASTONEA LABS LIMITED

ASTONEA LABS LIMITED Share Price
ISIN
INE0TG901011
Sector Market Cap
₹ 362.10 Cr

Astonea Labs Limited is an India-based company, which specializes in the manufacturing and marketing of a range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins. The Company also offers products for skin, tooth, and hair care, available in various forms, such as gels, ointments, creams, lotions, oils, and serums. Additionally, the Company is also involved in the trading of certain packing materials and raw materials used in pharmaceutical and cosmetic products. It manufactures and markets its own products under the brands Glow Up and Regero in the domestic market, wherein the products under Glow Up are also available through e-commerce platforms like Amazon and Tata 1MG. The Company also exports its products directly to countries such as Iraq and Yemen.

ASTONEA LABS LIMITED Financial Highlights

  • Revenue: ASTONEA LABS LIMITED reported revenue of ₹148.10 crore in FY26 vs ₹97.71 crore in FY25. It showed an increase of 51.57% on a yearly basis.
  • Operating Profit: ASTONEA LABS LIMITED reported an operating profit of ₹5.62 crore in FY26 vs ₹7.07 crore in FY25. It showed a decrease of 20.51% on a year-on-year basis.
  • Net Profit: ASTONEA LABS LIMITED reported a net profit of ₹4.52 crore in FY26 vs ₹5.35 crore in FY25. It showed a decrease of 15.51% on a yearly basis.
Know more
Promoters
72.30%
FII
0.00%
Other DII
0.07%
Retail and other
27.63%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
May 20258.01%
Jun 20258.01%
Sep 20252.51%
Mar 20260.00%
Mkt Cap Cr
0.00
P/E
35.60
P/B
2.82
ROE
11.97%
D/E
0.75
ROCE
10.47%
Div. Yield
0.00%
EPS(TTM)
4.49
Turnover
1.88
EV/EBITDA
14.53
Net Margin
3.06%
Op. Margin
9.50%
ROA
4.49%
Quick Ratio
0.95
Curr. Ratio
2.15
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Astonea Labs outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Astonea Labs appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ASTONEA LABS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹147.58₹97.52
Other Income₹0.52₹0.19
Total Revenue₹148.10₹97.71
Total Expenses₹142.48₹90.64
Profit Before Tax₹5.62₹7.07
Tax₹1.11₹1.72
Profit After Tax₹4.52₹5.35
EPS - Basic₹4.49₹6.94
EPS - Diluted₹4.49₹6.94

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹48.17₹32.53
Current Assets₹98.09₹70.85
Total Assets₹146.26₹103.38
Current Liabilities₹67.89₹65.00
Net Current Asset₹30.20₹5.85
Non-Current Liabilities₹21.24₹19.97
Equity Capital₹57.13₹18.41
Total Equity & Liabilities₹146.26₹103.38

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹147.58₹97.52₹80.19₹67.05
Other Income₹0.52₹0.19₹0.10₹0.21
Total Revenue₹148.10₹97.71₹80.29₹67.26
Total Expenses₹142.48₹90.64₹74.91₹66.18
Profit Before Tax₹5.62₹7.07₹5.38₹1.08
Tax₹1.11₹1.72₹1.31₹0.42
Profit After Tax₹4.52₹5.35₹4.07₹0.67
EPS - Basic₹4.49₹6.94₹5.36₹0.88
EPS - Diluted₹4.49₹6.94₹5.36₹0.88

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹7.07₹5.38₹1.08₹0.58
Income before WC changes₹14.80₹11.80₹7.18₹5.88
Change in Assets-₹16.21-₹12.99-₹12.00-₹20.90
Change in Liabilities₹14.12₹11.01₹4.15₹10.66
Change in WC-₹2.09-₹1.98-₹7.84-₹10.24
Cash flow from Operations₹9.25₹7.86-₹1.05-₹4.93
Cash flow from Investing-₹11.14-₹8.35-₹3.08-₹3.31
Cash flow from Financing₹1.62-₹0.26₹4.14₹8.17
Total Cash Flow-₹0.27-₹0.75₹0.01-₹0.07
Cash (Start of the year)₹0.36₹1.11₹0.03₹0.10
Cash (End of the year)₹0.09₹0.36₹0.04₹0.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹48.17₹32.53₹25.81₹21.72
Current Assets₹98.09₹70.85₹54.91₹42.55
Total Assets₹146.26₹103.38₹80.72₹64.28
Current Liabilities₹67.89₹62.94₹48.36₹36.50
Net Current Asset₹30.20₹7.91₹6.55₹6.06
Non-Current Liabilities₹21.24₹22.02₹20.50₹19.62
Equity Capital₹57.13₹18.41₹11.86₹8.16
Total Equity & Liabilities₹146.26₹103.38₹80.72₹64.28
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
65.72
Neutral
ATR (14)
14.86
Neutral
STOCH(9,6)
60.69
Neutral
STOCH RSI (14)
56.44
Neutral
ADX(9)
31.78
Bearish
UO(9)
66.71
Neutral
ROC(12)
20.53
Bullish
WillR(14)
-32.99
Neutral
Period
Simple value
Exponential vaue
5D
337.8
331.91
10D
311.48
317.77
20D
293.23
301.44
50D
277.33
275.75
100D
231.78
245.31
Volume trend — traded volume by day
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ASTONEA LABS LIMITED Share Price
ASTONEA LABS LIMITED
Pharmaceuticals
Add Stock
Add Another

ASTONEA LABS LIMITED Share Price FAQs

ASTONEA LABS LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837